Skip to main content

MAIA Biotechnology, Inc.

MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001878313

In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding MAIA Biotechnology, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of MAIA: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders3336+3
Shares13.2M13.5M+372.1K (+2.8%)
Value$18.4M$19.4M+$1.03M (+5.6%)

New holders (13)

Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to MAIA in Q2 2026
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC415,700$598.6K0.00%
Bleakley Financial Group, LLC181,623$261.5K0.00%
Two Sigma Investments, LP50,383$72.6K0.00%
Envestnet Asset Management Inc44,347$63.9K0.00%
Susquehanna International Group, LLP35,223$50.7K0.00%
Citadel Advisors LLC24,890$35.8K0.00%
Cetera Investment Advisers22,748$32.8K0.00%
Lazari Capital Management, Inc.21,750$31.3K0.01%
Atria Investments LLC21,100$30.4K0.00%
Barclays PLC4,152$5.98K0.00%
Tower Research Capital LLC (TRC)3,208$4.62K0.00%
Caitong International Asset Management Co., Ltd210$3020.00%
Wells Fargo & Company200$2880.00%

Sold out (10)

Institutions that held MAIA Biotechnology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of MAIA in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Corsair Capital Management, L.P.100,000$140.0K
Creative Planning28,602$40.0K
Ritholtz Wealth Management23,071$32.3K
O'Shaughnessy Asset Management, LLC20,071$28.1K
Catalyst Funds Management Pty Ltd10,800$15.1K
Cambridge Investment Research Advisors, Inc.10,620$15.0K
Curio Wealth, LLC2,000$2.80K
MAI Capital Management675$945
FMR LLC2$2
Royal Bank of Canada268$0